secwatch.observer — SEC 8-K summary
======================================

Issuer:     Wave Life Sciences Ltd. (WVE)
CIK:        0001631574
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001193125-23-205066
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Wave Life Sciences shareholders approve 6.5M share increase to equity plan and 2M to ESPP
--------------------------------------------------------------------------------

- Shareholders approved amendment to 2021 Equity Incentive Plan adding 6,500,000 authorized shares.
- Shareholders approved amendment to 2019 ESPP adding 2,000,000 authorized shares.
- All nine director nominees re-elected; highest votes against were 9.3M for Ken Takanashi.
- KPMG reappointed as auditor (99.9% for); advisory say-on-pay approved with 98.5% of votes cast.
- Over 84% quorum; 83.5 million of 98.98 million shares voted at annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1631574/000119312523205066/0001193125-23-205066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1631574/000119312523205066/d539015d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-205066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer